The current study revealed that MGMT/NUPR1 promoter hypomethylation and NDRG2/GL1 promoter hypermethylation correlate with GBM evolution, suggesting that they may play contrasting roles in GBM pathogenesis. This evidence concerns the gene NDRG2 and glioblastoma.